O'DONNELL CAROL A 4
4 · Apimeds Pharmaceuticals US, Inc. · Filed Nov 13, 2025
Insider Transaction Report
Form 4
O'DONNELL CAROL A
Director
Transactions
- Award
Stock Option (right to buy)
2025-11-11+10,000→ 10,000 totalExercise: $2.67Exp: 2035-11-11→ Common Stock, par value $0.01 per share (10,000 underlying)
Footnotes (1)
- [F1]The shares of common stock subject to the option shall vest in quarterly installments beginning October 1, 2025, such that the award shall be fully vested after three years subject to the reporting person's employment continuing through and on each vesting date. This option is not exercisable until stockholder approval is obtained to approve an amendment to the Company's incentive plan (the "Plan") to increase the number of shares of common stock available for issuance under the Plan. The shares of common stock subject to the option shall vest in full vest upon the occurrence of a Change in Control, as defined in the Plan.